II. Indications
- Pregnancy diagnosis and monitoring
-
Antenatal Screening (Quad Screen, Aneuploidy Screening)
- Free bHCG is increased in Trisomy 21
- Free bHCG is decreased in Trisomy 18
- Tumor monitoring
- Nonseminomatous germ cell tumor monitoring
- Hydatiform mole diagnosis and monitoring
- Choriocarcinoma diagnosis and monitoring
III. Precautions
- Urine Pregnancy Test (UPT) has a False Negative Rate of 1-2% (see below)
- Despite descriminatory levels as low as urine bHCG of 20 IU, False Negatives occur at higher bHCG levels
- UPT False Negative Rate is 3.6% in presentations of Pelvic Pain or Vaginal Bleeding (e.g. Ectopic Pregnancy)
- Confirm a negative Pregnancy Test with a serum HCG in high acuity cases or when clinical suspicion is high
- Kleinschmidt (2021) J Am Coll Emerg Physicians Open 2(3):e12427 +PMID: 33969349 [PubMed]
IV. Physiology
- HCG Function
- Prevents corpus luteum from involuting during pregnancy
- Allows for continued increase of Estrogen and Progesterone
- Stimulates Testosterone production in the male fetus Testes
- Prevents corpus luteum from involuting during pregnancy
- HCG is a GlycoproteinHormone with subunits a and b
- HCG shares the same alpha subunit with other Hormones (while Beta is unique to HCG)
- Components
- Composed of 65% polypeptides by molecular weight
- Composed of 35% large sugar side chains (8 chains)
- Four are N-Linked (2 each on alpha and beta)
- Four are O-Linked (all 4 are on beta subunit)
- Forms of HCG found in blood and urine
- Intact HCG with alpha and beta subunits
- Nicked HCG and nicked free beta subunit
- Free Beta hCG subunit and free alpha HCG subunit
- Hyperglycosylated free beta and free alpha subunits
- Beta core fragment (present only in urine)
- Measurement
- Urine and Blood HCG tests are specific for beta subunit
- Serum half life of HCG: 24 to 36 hours
- Discriminatory values at which bHCG is positive
- Urine bHCG: 20-25 IU/ml
- Serum bHCG: 10 IU/ml
V. Interpretation: Levels of bHCG in pregnancy
- Estimation in pregnancy for weeks 4 to 8 (plateaus after 10 weeks)
- Normal pregnancy
- bHCG may be detectable as early as 8 days after Ovulation
- Typically increases 80% every 48 hours (doubling every 48 to 72 hours)
- Minimal expected HCG increases
- HCG <1500 mIU/ml: Increases at least 49% in 48 hours
- HCG 1500-3000 mIU/ml: Increases at least 40% in 48 hours
- HCG >3000 mIU/ml: Increases at least 33% in 48 hours
- Barnhart (2016) Obstet Gynecol 128(3): 504-11 [PubMed]
- Fetal demise
- Decreases 20% every 48 Hours
- Ectopic Pregnancy
- Slower than expected rise in bHCG
- Faster than expected rise in bHCG
- Multiple Gestation
- Gestational Trophoblastic Disease (extremely high bHCG)
- Normal pregnancy
- Chart of corresponding Gestational age
- Day 23 (3.3 weeks): 100 mIU/ml (correlates with blastocyst implantation)
- Day 28 (4.0 weeks): 250 mIU/ml (approximate time of first missed Menses)
- Day 35 (5.0 weeks): 1000 mIU/ml
- bHCG 1800: Gestational Sac on Transvaginal U/S
- bHCG 3500: Gestational Sac on Transabdominal U/S
- Day 42 (6.0 weeks): 4000 mIU/ml
- Day 49 (7.0 weeks): 15000 mIU/ml
- bHCG 20,000: 5-10 mm Embryo with cardiac activity
- Day 56 (8.0 weeks): 65000 mIU/ml
- Decreases gradually after 8 weeks
- Plateaus after 20 weeks
- Ranges of bHCG over each Trimester
- First Trimester: 30,000 to 100,000 mIU/ml
- Second Trimester: 10,000 to 30,000 mIU/ml
- Third Trimester: 5,000 to 15,000 mIU/ml
VI. Efficacy
- Commercial Pregnancy Tests (bedside Pregnancy Test)
- Approved for urine and serum samples
- Qualitative Urine Pregnancy Test
- Whole blood may also be used (e.g. Emergency Department)
- Wait at least 10 minutes before interpreting test
- Bedside whole blood method in 10 minutes
- Much faster than the alternative serum result from lab in over 1 hour
- Test Sensitivity: 96%
- Test Specificity: 100%
- Negative Predictive Value: 98%
- Misses cases where bHCG is <50
- Confirmatory testing is needed for negative tests (or repeat testing in 48-72 hours)
- References
- Home Pregnancy Tests
- Variable efficacy after missed Menses
- Wide discrepancy between brands
- Cole (2004) Am J Obstet Gynecol 190:100-5 [PubMed]
VII. Causes: Elevated bHCG in Non-Pregnant State
- HCG-producing tumors in women (extremely high bHCG)
- HCG-producing tumors in men
- HCG is usually undetectable in healthy males
- Nonseminomatous germ cell tumor (Testicular Cancer)
- Used with AFP for monitoring
VIII. Causes: False Positive increased serum hCG
- Causes
- Heterophilic Antibody (most common)
- Human anti-mouse Antibody (HAMA)
- Nonspecific Protein-binding hCG-like substances
- Red Blood Cell interference
- Marijuana use
- Hypogonadism
- Confirmation methods in non-pregnant conditions
- Qualitative urine hCG
- Serum hCG by different immunoassay method
- Serial dilutions of serum hCG sample
IX. Causes: False Negative Urine bHCG
- Dilute urine
- High Vitamin C intake
- Processing error
- Hook Effect
- Detection is via free and fixed antibodies that bind HCG in a "sandwhich"
- Excess intact HCG fragments saturate antibodies and prevent detection (False Negative)
- Variant Hook Effect
- HCG variants present later in pregnancy may not be detected by some assays
- References
X. Interpretation: HCG in Nonseminomatous germ cell tumor (Men)
- Interpretation
- Poor prognosis if bHCG >50,000 mIU/ml at diagnosis
- Five year survival rate: 50%
- Efficacy
- High Specificity in men
- Low Test Sensitivity
- HCG or AFP increased in 85% of patients
- HCG or AFP increased in only 20% of Stage 1 Cancer
- Protocol
- Initial: bHCG with AFP q1-2 months for 1 year
- Later: bHCG with AFP q3 months for 1 year
XI. References
- Bakerman, ABCs Interpretive Lab Data, p. 239-40
- (1997) J Clin Oncol 15:594-603 [PubMed]
- Hay (1988) J Clin Endocrinol Metab 67:1322-4 [PubMed]